| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2018 ( Subtotal = -$286,700 ) |
| | 2018 | 2016 | ACORDA THERAPEUTICS, INC. | 420 SAW MILL RIVER RD | ARDSLEY | NY | 10502-2605 | WESTCHESTER | USA | U01NS076474 | Translational Development of Glial Growth Factor 2 (GGF2) for the Treatment of St | 000 | 2 | NIH | 1/9/2018 | -$286,700 |
|
| Issue Date FY: 2016 ( Subtotal = $889,977 ) |
| | 2016 | 2016 | ACORDA THERAPEUTICS, INC | 420 SAW MILL RIVER ROAD | ARDSLEY | NY | 10502 | WESTCHESTER | USA | U01NS076474 | Translational Development of Glial Growth Factor 2 (GGF2) for the Treatment of St | 000 | 2 | NIH | 9/2/2016 | $889,977 |
|
| Issue Date FY: 2015 ( Subtotal = $0 ) |
| | 2015 | 2014 | ACORDA THERAPEUTICS, INC | 420 SAW MILL RIVER ROAD | ARDSLEY | NY | 10502 | WESTCHESTER | USA | U01NS076474 | Translational Development of Glial Growth Factor 2 (GGF2) for the Treatment of St | 000 | 1 | NIH | 8/17/2015 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $476,872 ) |
| | 2014 | 2014 | ACORDA THERAPEUTICS, INC | 420 SAW MILL RIVER ROAD | ARDSLEY | NY | 10502 | WESTCHESTER | USA | U01NS076474 | Translational Development of Glial Growth Factor 2 (GGF2) for the Treatment of St | 000 | 1 | NIH | 9/12/2014 | $476,872 |
|
| Issue Date FY: 2005 ( Subtotal = $494,030 ) |
| | 2005 | 2005 | ACORDA THERAPEUTICS, INC | 15 SKYLINE DRIVE | HAWTHORNE | NY | 10532 | WESTCHESTER | USA | R43NS052921 | EFFECTS OF CHONDROITINASE AND TRAINING IN ACUTE SCI | 000 | 1 | NIH | 9/7/2005 | $156,491 |
| | 2005 | 2005 | ACORDA THERAPEUTICS, INC | 15 SKYLINE DRIVE | HAWTHORNE | NY | 10532 | WESTCHESTER | USA | R43NS050894 | CHIMERIC PROTEINS FOR THE TREATMENT OF SPINAL CORD INJURY | 000 | 1 | NIH | 9/12/2005 | $153,151 |
| | 2005 | 2005 | ACORDA THERAPEUTICS, INC | 15 SKYLINE DRIVE | HAWTHORNE | NY | 10532 | WESTCHESTER | USA | R43NS051863 | MOLECULAR EVOLUTION OF CHONDROITINASE ABCI FOR SCI | 000 | 1 | NIH | 9/12/2005 | $184,388 |
|
| Issue Date FY: 2004 ( Subtotal = $66,405 ) |
| | 2004 | 2004 | ACORDA THERAPEUTICS, INC | 15 SKYLINE DRIVE | HAWTHORNE | NY | 10532 | WESTCHESTER | USA | R42NS040172 | HUMAN MONOCOLONAL ANTIBODIES FOR CNS REMYELINATION | 001 | 3 | NIH | 1/16/2004 | $66,405 |
|
| Issue Date FY: 2003 ( Subtotal = $540,071 ) |
| | 2003 | 2003 | ACORDA THERAPEUTICS, INC | 15 SKYLINE DRIVE | HAWTHORNE | NY | 10532 | WESTCHESTER | USA | R42NS040172 | HUMAN MONOCOLONAL ANTIBODIES FOR CNS REMYELINATION | 001 | 2 | NIH | | $45,225 |
| | 2003 | 2003 | ACORDA THERAPEUTICS, INC | 15 SKYLINE DRIVE | HAWTHORNE | NY | 10532 | WESTCHESTER | USA | R42NS040172 | HUMAN MONOCOLONAL ANTIBODIES FOR CNS REMYELINATION | 000 | 3 | NIH | 9/30/2003 | $387,546 |
| | 2003 | 2003 | ACORDA THERAPEUTICS, INC | 15 SKYLINE DRIVE | HAWTHORNE | NY | 10532 | WESTCHESTER | USA | R43NS046821 | RELEASE CHONDROITINASE SYSTEMS FOR SPINAL CORD INJURY | 000 | 1 | NIH | 8/22/2003 | $107,300 |
|
| Issue Date FY: 2002 ( Subtotal = $526,174 ) |
| | 2002 | 2002 | ACORDA THERAPEUTICS, INC | 15 SKYLINE DRIVE | HAWTHORNE | NY | 10532 | WESTCHESTER | USA | R42NS040172 | HUMAN MONOCOLONAL ANTIBODIES FOR CNS REMYELINATION | 000 | 2 | NIH | 9/30/2002 | $526,174 |
|
| Issue Date FY: 2001 ( Subtotal = $239,371 ) |
| | 2001 | 2001 | ACORDA THERAPEUTICS, INC | 15 SKYLINE DRIVE | HAWTHORNE | NY | 10532 | WESTCHESTER | USA | R43NS041685 | TENASCIN-C-FRAGMENTS FOR SPINAL CORD REGENERATION | 000 | 1 | NIH | 7/25/2001 | $100,000 |
| | 2001 | 2001 | ACORDA THERAPEUTICS, INC | 15 SKYLINE DRIVE | HAWTHORNE | NY | 10532 | WESTCHESTER | USA | R43NS039713 | ANTISENSE TECHNOLOGY FOR NEURAL PROTECTION AND REPAIR | 000 | 1 | NIH | 8/22/2001 | $139,371 |
|
| Issue Date FY: 2000 ( Subtotal = $295,526 ) |
| | 2000 | 2000 | ACORDA THERAPEUTICS, INC | 420 SAW MILL RIVER ROAD | ARDSLEY | NY | 10502 | WESTCHESTER | USA | R43NS040209 | HUMAN ANTIBODIES TO PROMOTE CNS REGENERATION | 000 | 1 | NIH | 9/20/2000 | $100,000 |
| | 2000 | 2000 | ACORDA THERAPEUTICS, INC | 420 SAW MILL RIVER ROAD | ARDSLEY | NY | 10502 | WESTCHESTER | USA | R41NS040172 | HUMAN MONOCLONAL ANTIBODIES FOR CNS REGENERATION | 000 | 1 | NIH | 9/30/2000 | $134,526 |
| | 2000 | 2000 | ACORDA THERAPEUTICS, INC | 420 SAW MILL RIVER ROAD | ARDSLEY | NY | 10502 | WESTCHESTER | USA | R41NS040172 | HUMAN MONOCLONAL ANTIBODIES FOR CNS REGENERATION | 000 | 1 | NIH | 9/30/2000 | $61,000 |
|
| Issue Date FY: 1999 ( Subtotal = $99,995 ) |
| | 1999 | 1999 | ACORDA THERAPEUTICS, INC | 420 SAW MILL RIVER ROAD | ARDSLEY | NY | 10502 | WESTCHESTER | USA | R41HD037353 | PROMOTION OF NERVE REGENERATION BY FRAGMENTS OF L1 | 000 | 1 | NIH | 8/30/1999 | $99,995 |
|
| Issue Date FY: 1997 ( Subtotal = $99,173 ) |
| | 1997 | | ACORDA THERAPEUTICS, INC | 420 SAW MILL RIVER ROAD | ARDSLEY | NY | 10502 | WESTCHESTER | USA | R41GM56556 | SELF ASSEMBLING PEPTIDE SUBSTRATES FOR CNS THERAPIES | 000 | 01 | NIH | 9/25/1997 | $99,173 |
|
| Issue Date FY: 1996 ( Subtotal = $99,662 ) |
| | 1996 | | ACORDA THERAPEUTICS, INC | 420 SAW MILL RIVER ROAD | ARDSLEY | NY | 10502 | WESTCHESTER | USA | R43HD34345 | 4-AP THERAPY OF CHRONIC PAIN AND SPINAL INJURY | 000 | 01 | NIH | 9/24/1996 | $99,662 |
|
|
